Free tool
FAERS Monitor: Dextenza
Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations
Reports naming NDA 208742 or its brand name (Dextenza, Dexamethasone). Reports on generic versions are filed under their own applications.
Reports
295,403
Serious
250,069
85% of reports
Hospitalization
114,035
Death reported
48,053
Any cause; not necessarily from the drug
Most reported reactions
MedDRA preferred terms.
- off label use22,661
- fatigue17,491
- diarrhoea17,299
- plasma cell myeloma14,401
- nausea14,166
- pneumonia13,815
- death13,363
- drug ineffective13,179
- neutropenia11,779
- pyrexia11,104
- thrombocytopenia10,770
- dyspnoea10,382
- febrile neutropenia9,199
- anaemia9,123
- vomiting8,877
Reports by year received
View as table
| Year | Reports |
|---|---|
| 2004 | 1,561 |
| 2005 | 2,135 |
| 2006 | 1,096 |
| 2007 | 875 |
| 2008 | 1,308 |
| 2009 | 1,923 |
| 2010 | 3,580 |
| 2011 | 5,377 |
| 2012 | 6,679 |
| 2013 | 6,720 |
| 2014 | 8,343 |
| 2015 | 17,378 |
| 2016 | 15,820 |
| 2017 | 17,840 |
| 2018 | 23,304 |
| 2019 | 23,260 |
| 2020 | 25,188 |
| 2021 | 28,943 |
| 2022 | 27,273 |
| 2023 | 24,148 |
| 2024 | 21,459 |
| 2025 | 18,425 |
| 2026 | 12,766 |
Disproportionality screen
Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 20,758,756 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.
| Reaction | Reports | PRR | 95% CI lower | Chi-squared |
|---|---|---|---|---|
| plasma cell myelomaSignal | 14,401 | 41.0 | 40.2 | 355,834 |
| febrile neutropeniaSignal | 9,199 | 11.3 | 11.1 | 74,634 |
| thrombocytopeniaSignal | 10,770 | 7.5 | 7.3 | 54,938 |
| neutropeniaSignal | 11,779 | 6.7 | 6.5 | 52,064 |
| anaemiaSignal | 9,123 | 3.5 | 3.5 | 15,866 |
| pneumoniaSignal | 13,815 | 3.1 | 3.1 | 19,455 |
| pyrexiaSignal | 11,104 | 2.3 | 2.3 | 8,272 |
| diarrhoea | 17,299 | 1.9 | 1.9 | 7,822 |
| off label use | 22,661 | 1.9 | 1.8 | 9,240 |
| fatigue | 17,491 | 1.6 | 1.6 | 4,140 |
| vomiting | 8,877 | 1.4 | 1.3 | 812 |
| dyspnoea | 10,382 | 1.3 | 1.3 | 775 |
| nausea | 14,166 | 1.3 | 1.3 | 882 |
| death | 13,363 | 1.1 | 1.1 | 139 |
| drug ineffective | 13,179 | 0.7 | 0.7 | 1,661 |
A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.